Analyst Reco. Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 12:20:00 2026-03-12 EDT			5-day change	1st Jan Change
247.00 ^DKK	-1.12%		-0.66%	-24.06%

08:00am	Berenberg cuts Novo Nordisk price target on Cagrisema outlook - BN	FW
07:23am	Tellus Midas declined 1.30 percent in February - increased cash position	FW

Analyst Reco.

08:00am	Berenberg cuts Novo Nordisk price target on Cagrisema outlook - BN	FW
05:29am	Novo Nordisk Price Target Cut as Berenberg Expects Lower CagriSema Sales Amid Recent Clinical Data	MT
02:44am	Berenberg lowers price target for Novo Nordisk to 300 Danish kroner (360), reiterates buy - BN	FW
02:42am	NOVO NORDISK : Receives a Buy rating from Berenberg	ZD
03-11	Santander initiates coverage on Novo Nordisk with outperform rating	FW
03-11	Grupo Santander Starts Novo Nordisk Coverage at Outperform	MT
03-10	BofA Upgrades Hims & Hers Health to Neutral From Underperform as 'Worst Case De-Risked', Lifts Price Target to $23 From $12.50	MT
03-10	Hims & Hers' Deal With Novo Nordisk Removes Litigation, Credit Risks, BofA Says	MT
03-10	TD Cowen downgrades Novo Nordisk to hold – sees major challenges following semaglutide patent expiry	FW
03-10	TD Cowen Downgrades Novo Nordisk to Hold Rating, Trims PT	MT
03-10	TD Cowen Downgrades Novo Nordisk to Hold From Buy, Adjusts PT to $42 From $45	MT
03-10	TD Cowen downgrades Novo Nordisk to hold (buy), price target 270 Danish kroner - BN	FW
03-09	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
03-09	NOVO NORDISK : JP Morgan gives a Neutral rating	ZD
03-06	NOVO NORDISK : Barclays reaffirms its Neutral rating	ZD
03-03	Morgan Stanley Upgrades Novo Nordisk to Equalweight From Underweight, Adjusts Price Target to $40 From $42	MT
03-03	Morgan Stanley Upgrades Novo Nordisk After Share Price Plunge, Sees More Balanced Valuation	FW
03-03	NOVO NORDISK : Barclays remains Neutral	ZD
03-03	DNB Carnegie Lowers Price Target for Novo Nordisk to 420 Danish Kroner (430), Reiterates Buy	FW
03-03	Morgan Stanley Upgrades Novo Nordisk to Equal Weight (from Underweight), Sets Price Target at 250 Danish Kroner - BN	FW
03-02	Global markets live: Amazon, AWS, Lufthansa, Saudi Aramco, Standard Chartered…
03-02	Goldman Sachs Downgrades Novo Nordisk to Neutral From Buy, Adjusts PT to $41 From $63	MT
03-02	Goldman Sachs Downgrades Novo Nordisk to Neutral, Cuts PT	MT
03-02	Goldman Sachs Drops Buy Recommendation on Novo Nordisk Following Study Data	FW
03-02	NOVO NORDISK : Goldman Sachs is less optimistic	ZD